• Latest
  • Trending
sebi

SEBI bars Omaxe, its Chairman and MD from securities market for 2 years

July 31, 2024
heart attack

Study shows kidney drug can boost treatment for heart attack patients

September 2, 2024
Swaminathan

RBI’s stringent actions intended to protect customers: Swaminathan

September 2, 2024
Dhanush, Shourya and Vania

Dhanush, Shourya and Vania trio break world record in Air Rifle at Deaf World Championships

September 2, 2024
Indian equity indices opened flat on August 29 due to negative cues from Asian and US markets

Sensex closes above 82,500 points for first time ever

September 2, 2024
coal

India’s coal production sees 6.48 pc growth at 384 MT in April-August

September 2, 2024
railways

Cabinet nod to Rs 18,036 cr project to connect Mumbai, Indore via shortest rail route

September 2, 2024
telecom manufacturing

Aim to democratise telecom services under Digital Bharat Nidhi initiative

September 2, 2024
ace ev

Indian commercial vehicle industry reverses decline, to see modest growth in FY25

September 2, 2024
India’s manufacturing growth

India’s manufacturing growth eases in August, stays above long-run average

September 2, 2024
Supreme Court

SC dismisses PIL seeking caste-based census

September 2, 2024

Indian Navy’s P-8I lands in France, marking its first ever deployment in Europe

September 2, 2024
PM Modi congratulates Nishad Kumar

PM Modi congratulates Nishad Kumar on winning silver medal in Paralympics

September 2, 2024
Blitz India UK Edition
Contact
Download
  • Home
  • Booming Britain
  • G20 Podium
  • Legal
  • Specials
  • National
    • East
    • West
    • South
    • North
  • News
  • Education
  • Videos
  • Contact
No Result
View All Result
Welcome To Blitz India Media
No Result
View All Result

SEBI bars Omaxe, its Chairman and MD from securities market for 2 years

by Blitzindiamedia
July 31, 2024
in News
0
sebi
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

YOU MAY ALSO LIKE

Study shows kidney drug can boost treatment for heart attack patients

RBI’s stringent actions intended to protect customers: Swaminathan

Blitz Bureau

NEW DELHI: In a jolt to real estate company Omaxe, the Securities and Exchange Board of India (SEBI) banned the company’s top management, including Chairman Rohtas Goel, from the securities market for two years. The markets regulator also barred the company’s Managing Director Mohit Goel and three others from the securities market for irregularities in the company’s financial statements.
The SEBI said in its “final order in the matter of misstatements and irregularities in the financial statements of Omaxe Limited and that these people have been prohibited from holding any position as Director or Key Managerial Person of any other listed company for two years.”
SEBI also imposed a Rs 47 lakh fine on 16 entries which need to be paid within 45 days.
“SEBI was in receipt of complaints against Omaxe Limited for fraudulent transactions, diverted/siphoned of funds, misrepresented the financial statements, inflated turnover etc,” read the 126-page order.
According to the markets regulator, the real estate company misrepresented the financial statements during 2018-19, 2019-20, and 2020-21 including revenue, debtors, advances, and expenses. The fraud was never disclosed to the shareholders of Omaxe.

Blitzindiamedia News Subscription

Search

No Result
View All Result
Welcome To Blitz India Media

© 2023 Blitz India Media -Blitz India Building A New Nation

Navigate Site

  • Booming Britain
  • G20 Podium
  • New India
  • Legal
  • Contact

Follow Us

No Result
View All Result
  • Home
  • News
  • The Blitz
  • G20 Podium
  • National
    • East
    • West
    • South
    • North
  • Focus
  • Opinion
  • Booming Britain
  • Perspective
  • Legal
  • Specials
  • Download

© 2023 Blitz India Media -Blitz India Building A New Nation